Relay Therapeutics, Inc. (RLAY) Tops Q2 EPS by 4c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q2 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• AIRO Group Holdings, Inc. (AIRO) Reports Q2 Loss of $0.06